Search Results - "Farahmand, Leila"
-
1
Breast cancer: Biology, biomarkers, and treatments
Published in International immunopharmacology (01-07-2020)“…•BCSCs are the most critical cells leading to chemo and radio-resistance in tumor therapy.•Signaling pathways/metabolic components in BCSC could be targeted as…”
Get full text
Journal Article -
2
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Published in Cancer cell international (10-08-2021)“…Abstract Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-positive breast cancers and all receptor tests come back…”
Get full text
Journal Article -
3
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
Published in British journal of cancer (18-05-2022)“…Extracellular matrix (ECM) refers to the non-cellular components of the tumour microenvironment, fundamentally providing a supportive scaffold for cellular…”
Get full text
Journal Article -
4
Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies
Published in Journal of cellular physiology (01-05-2019)“…It is now fully recognized that along with multiple physiological functions, angiogenesis is also involved in the fundamental process and pathobiology of…”
Get full text
Journal Article -
5
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
Published in Cancer cell international (09-04-2021)“…VEGF and its receptor family (VEGFR) members have unique signaling transduction system that play significant roles in most pathological processes, such as…”
Get full text
Journal Article -
6
Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms
Published in Applied microbiology and biotechnology (01-08-2020)“…Severe side effects of chemotherapy as well as drug resistance highlight the ongoing need to discover novel natural bioactive compounds with anticancer…”
Get full text
Journal Article -
7
The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
Published in Probiotics and antimicrobial proteins (01-10-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), causing the 2019 novel coronavirus disease (COVID-19), was introduced by WHO (World Health…”
Get full text
Journal Article -
8
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer
Published in Molecular therapy. Nucleic acids (16-06-2017)“…Triple negative breast cancer (TNBC) is the most aggressive and lethal subtype of breast cancer. It is associated with a very poor prognosis and intrinsically…”
Get full text
Journal Article -
9
The antiproliferative effects of cold atmospheric plasma‐activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism
Published in Journal of cellular physiology (01-05-2019)“…Recent studies have proven several promising anticancer activities for cold atmospheric plasma (CAP) against a wide range of cancer cells in vitro. Recently,…”
Get full text
Journal Article -
10
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
Published in Cancer cell international (05-03-2022)“…Although resistance is its major obstacle in cancer therapy, trastuzumab is the most successful agent in treating epidermal growth factor receptor 2 positive…”
Get full text
Journal Article -
11
Monoclonal antibody‐based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
Published in Journal of pharmacy and pharmacology (01-07-2018)“…Objectives Monoclonal antibody‐based of cancer therapy has been considered as one of the most successful therapeutic strategies for both haematologic…”
Get full text
Journal Article -
12
NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer
Published in Tumor Biology (01-06-2017)“…Graphical abstract Although accounting for merely a minute portion of diagnosed breast cancers, disproportionate number of deaths and associated low survival…”
Get full text
Book Review Journal Article -
13
Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides
Published in Drug delivery (01-11-2017)“…As a prototypical pro-inflammatory transcription factor, constitutive activation of NF-κB signaling pathway has been reported in several chronic inflammatory…”
Get full text
Journal Article -
14
Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines
Published in Chemical papers (01-04-2023)“…Breast cancer is one of the most common cancers among women. Antibodies are used to deliver a specific drug to the tumor area. Nanotechnology and monoclonal…”
Get full text
Journal Article -
15
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors
Published in Molecular oncology (01-01-2022)“…Alteration in glycosylation pattern of MUC1 mucin tandem repeats during carcinomas has been shown to negatively affect adhesive properties of malignant cells…”
Get full text
Journal Article -
16
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
Published in Cancer cell international (19-08-2022)“…Abstract As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling…”
Get full text
Journal Article -
17
Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity
Published in Iranian journal of immunology (01-09-2023)“…Trastuzumab is a humanized monoclonal antibody that targets site-specifically human epidermal growth factor-2 receptor (HER2) cell surface antigen…”
Get full text
Journal Article -
18
MED1 may explain the interaction between receptor tyrosine kinases and ERα66 in the complicated network of Tamoxifen resistance
Published in European journal of pharmacology (05-06-2017)“…According to the American Society of Clinical Oncology or ASCO's clinical practice guidelines, administration of Tamoxifen for hormone receptor positive…”
Get full text
Journal Article -
19
Metas-Chip precisely identifies presence of micrometastasis in live biopsy samples by label free approach
Published in Nature communications (19-12-2017)“…Detecting the micrometastasis is a major challenge in patients’ survival. The small volume of the biopsied tissue results in limited number of…”
Get full text
Journal Article -
20
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study
Published in Cancer cell international (09-01-2022)“…Mucin-1 (MUC-1) is a transmembrane glycoprotein, which bears many similarities between dogs and humans. Since the existence of animal models is essential to…”
Get full text
Journal Article